KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Inventory (2020 - 2025)

Boston Scientific (BSX) has disclosed Change in Inventory for 6 consecutive years, with $50.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 208.7% to $50.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $188.0 million through Dec 2025, down 17.54% year-over-year, with the annual reading at $188.0 million for FY2025, 17.54% down from the prior year.
  • Change in Inventory hit $50.0 million in Q4 2025 for Boston Scientific, down from $94.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $215.0 million in Q3 2021 to a low of -$65.0 million in Q2 2025.
  • Historically, Change in Inventory has averaged $87.1 million across 5 years, with a median of $94.5 million in 2022.
  • Biggest five-year swings in Change in Inventory: skyrocketed 714.29% in 2021 and later crashed 177.97% in 2024.
  • Year by year, Change in Inventory stood at $31.0 million in 2021, then skyrocketed by 48.39% to $46.0 million in 2022, then rose by 28.26% to $59.0 million in 2023, then tumbled by 177.97% to -$46.0 million in 2024, then skyrocketed by 208.7% to $50.0 million in 2025.
  • Business Quant data shows Change in Inventory for BSX at $50.0 million in Q4 2025, $94.0 million in Q3 2025, and -$65.0 million in Q2 2025.